Catalyst
Slingshot members are tracking this event:
Phase 3 data from second trial of Elagolix for Endometriosis due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NBIX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 10, 2016
Occurred Source:
http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-newsArticle&ID=2137243
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Elagolix, Endometriosis, Phase 3
